沐邦高科
(603398)
| 流通市值：58.25亿 | | | 总市值：73.72亿 |
| 流通股本：3.43亿 | | | 总股本：4.34亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,016,479,848.93 | 640,405,527.71 | 345,258,607.16 | 944,322,602.56 |
| 营业收入 | 1,016,479,848.93 | 640,405,527.71 | 345,258,607.16 | 944,322,602.56 |
| 已赚保费 | 0 | - | - | - |
| 手续费及佣金收入 | 0 | - | - | - |
| 二、营业总成本 | 986,636,205.84 | 627,926,890.89 | 301,898,065.49 | 963,714,209.14 |
| 营业成本 | 810,647,972.52 | 508,546,741.26 | 240,209,561.25 | 761,383,004.01 |
| 利息支出 | 0 | - | - | - |
| 手续费及佣金支出 | 0 | - | - | - |
| 退保金 | 0 | - | - | - |
| 赔付支出净额 | 0 | - | - | - |
| 提取保险合同准备金净额 | 0 | - | - | - |
| 保单红利支出 | 0 | - | - | - |
| 分保费用 | 0 | - | - | - |
| 税金及附加 | 3,639,756.01 | 2,019,002.82 | 1,172,801.13 | 7,488,241.8 |
| 销售费用 | 17,404,443.06 | 12,459,013.74 | 6,916,560.75 | 53,943,853 |
| 管理费用 | 98,636,763.66 | 71,357,137.78 | 33,760,255.06 | 95,854,881.23 |
| 研发费用 | 34,580,554.77 | 20,830,618.7 | 11,051,810.51 | 32,637,725.35 |
| 财务费用 | 21,726,715.82 | 12,714,376.59 | 8,787,076.79 | 12,406,503.75 |
| 其中:利息费用 | 19,357,154.57 | 11,169,115.8 | 8,216,744.71 | 12,878,732.83 |
| 其中:利息收入 | 429,174.2 | -37,036.35 | 104,731.58 | 864,461.41 |
| 加:公允价值变动收益 | 0 | - | - | - |
| 加:投资收益 | 0 | - | - | -373,106 |
| 净敞口套期收益 | 0 | - | - | - |
| 汇兑收益 | 0 | - | - | - |
| 资产处置收益 | -493,068.61 | -493,068.61 | -477,879.5 | 294,316.98 |
| 资产减值损失(新) | -9,799,309.58 | -6,795,315.21 | -3,518,643.96 | -176,034,941.45 |
| 信用减值损失(新) | -4,013,289.93 | -693,540.08 | -1,108,096.6 | -13,155,346.74 |
| 其他收益 | 9,034,140.69 | 8,693,840.44 | 8,465,938.68 | 898,548.76 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 24,572,115.66 | 13,190,553.36 | 46,721,860.29 | -207,762,135.03 |
| 加:营业外收入 | 434,196.71 | 429,310.21 | 491,810.71 | 141,680.54 |
| 减:营业外支出 | 944,423.7 | 562,834.87 | - | 5,645,695.61 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 24,061,888.67 | 13,057,028.7 | 47,213,671 | -213,266,150.1 |
| 减:所得税费用 | 8,975,263.74 | 1,833,633.47 | 13,668,822.29 | 15,811,334.09 |
| 六、净利润 | 15,086,624.93 | 11,223,395.23 | 33,544,848.71 | -229,077,484.19 |
| 持续经营净利润 | 15,086,624.93 | 11,223,395.23 | 33,544,848.71 | -229,077,484.19 |
| 终止经营净利润 | 0 | - | - | - |
| 归属于母公司股东的净利润 | 15,988,537.87 | 11,482,340.18 | 33,653,171.69 | -228,762,092.64 |
| 少数股东损益 | -901,912.94 | -258,944.95 | -108,322.98 | -315,391.55 |
| (一)基本每股收益 | 0.05 | 0.03 | 0.1 | -0.67 |
| (二)稀释每股收益 | 0.05 | 0.03 | 0.1 | -0.67 |
| 八、其他综合收益 | 0 | - | - | - |
| 归属于母公司股东的其他综合收益 | 0 | - | - | - |
| 九、综合收益总额 | 15,086,624.93 | 11,223,395.23 | 33,544,848.71 | -229,077,484.19 |
| 归属于母公司股东的综合收益总额 | 15,988,537.87 | 11,482,340.18 | 33,653,171.69 | -228,762,092.64 |
| 归属于少数股东的综合收益总额 | -901,912.94 | -258,944.95 | -108,322.98 | -315,391.55 |
| 公告日期 | 2023-10-31 | 2023-08-31 | 2023-04-28 | 2023-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |